Garware Fulflex has finalized the acquisition of a fully automated medical products manufacturing facility in the United States, marking a significant expansion of its North American operations.
The 300,000-square-foot site is located in Jacksonville, Texas, and represents a strategic move by the Indian flexible packaging company to diversify beyond its traditional core business into the higher-growth medical sector.
The transaction underscores a broader trend among Indian industrial firms seeking to establish or expand manufacturing capabilities in the US, leveraging automation to compete in specialized niches.
By securing a fully automated facility, Garware Fulflex aims to enhance production efficiency and reduce lead times for its medical product lines, potentially improving margins in a competitive market.
This development aligns with the company's long-term strategy to internationalize its revenue base and reduce dependence on the domestic Indian market.
The acquisition provides immediate capacity and technological infrastructure, allowing the firm to scale its medical offerings without the lead time associated with greenfield construction.